CRISPR-TB
Live / Applied — Response to non-final action entered (as of 05 Oct 2026)
What this means for you
Not registered yet, but its 12 Dec 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99545109
- Mark type
- Word mark
- Filed
- 12 Dec 2025
Goods and services
- Class 001 — Chemicals: Chemical, biochemical, and biological reagents for scientific, laboratory, or research use, namely CRISPR-based molecular detection reagents, guide RNAs, enzymes, buffers, and associated components for detecting Mycobacterium tuberculosis in biological samples.
- Class 005 — Pharmaceuticals: Medical diagnostic reagents and diagnostic test kits consisting primarily of medical diagnostic reagents for the detection of infectious diseases, including Mycobacterium tuberculosis, in blood or other biological samples using CRISPR-based nucleic acid detection methods.
Owner
- IGDX, Inc., Houston, TX, US
Prosecution history
- 05 Oct 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Oct 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Jul 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 13 Jul 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 18 May 2026 — DIVISIONAL PROCESSING COMPLETE
- 12 May 2026 — DIVISIONAL REQUEST RECEIVED
- 18 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 May 2026 — ASSIGNED TO LIE
- 12 May 2026 — TEAS REQUEST TO DIVIDE RECEIVED
- 16 Apr 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Apr 2026 — NON-FINAL ACTION E-MAILED
- 16 Apr 2026 — NON-FINAL ACTION WRITTEN
- 16 Apr 2026 — ASSIGNED TO EXAMINER
- 06 Apr 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED